Overview

Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare two types of low-molecular-weight heparin, enoxaparin and bemiparin, as regards their efficacy and safety in venous thromboembolism prevention among intensive care unit patients.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mohamed Sayed Mohamed Abbas
Treatments:
Bemiparin
Enoxaparin
Heparin, Low-Molecular-Weight
Criteria
Inclusion Criteria:

- Sepsis , stroke , major burn , respiratory failure , traumatic brain injury ,
malignancy and post arrest who are intubated and mechanically ventilated on continuous
IV sedation

Exclusion Criteria:

- Hypersensitivity to low molecular weight heparins , hypercoagulability , congenital or
acquired bleeding disorder, prolongation of activated partial thromboplastin time or
prothrombin time by 20% compared to normal values; thrombocytopenia (platelet count
<100,000/mm3); macroscopic hematuria; uncontrolled hypertension [systolic blood
pressure >200 mmHg; diastolic blood pressure >100 mmHg]; impaired kidney function:
serum creatinine > 2.0 mg/ dL and bleeding gastrointestinal ulcer.